Universal Health International Group Holding Ltd. (HK:2211)
:2211
Top Page
Universal Health International Group Holding Ltd.
(2211)
Select Model
Select Model
Rating:58Neutral
Price Target:
HK$1.50
▼(-10.18% Downside)
Action:N/ADate:07/19/25
The overall score of 58 for HK:2211 reflects significant concerns in financial performance, with declining revenue and negative cash flows posing key risks. However, strong technical momentum and an attractive P/E ratio provide some upside potential. Financial health remains the primary drag on the score, while technicals offer a counterbalancing positive outlook.
Positive Factors
Strategic Share Capital Increase
The increase in share capital enhances financial flexibility, supporting growth initiatives and potentially improving market positioning.
Negative Factors
Declining Revenue
Declining revenue indicates challenges in market demand or competitive positioning, potentially impacting long-term growth prospects.
Read all positive and negative factors
Positive Factors
Negative Factors
Strategic Share Capital Increase
The increase in share capital enhances financial flexibility, supporting growth initiatives and potentially improving market positioning.
Read all positive factors
Universal Health International Group Holding Ltd. (2211) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$68.54M
Dividend YieldN/A
Average Volume (3M)554.01K
Price to Earnings (P/E)―
Beta (1Y)1.02
Revenue Growth-34.73%
EPS Growth-4642.86%
CountryHK
Employees1,198
SectorHealthcare
Sector Strength45
IndustryMedical - Pharmaceuticals
Share Statistics
EPS (TTM)-0.07
Shares Outstanding110,546,220
10 Day Avg. Volume803,972
30 Day Avg. Volume554,009
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.27
Price to Sales (P/S)0.12
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Universal Health International Group Holding Ltd. Business Overview & Revenue Model
Company Description
Universal Health International Group Holding Limited, an investment holding company, engages in the distribution, wholesale, and retail of drugs, healthcare products, and other pharmaceutical products in the northeastern region of the People's Rep...
How the Company Makes Money
Universal Health International Group Holding Ltd. generates revenue through the sale of pharmaceutical and healthcare products. Its primary revenue streams include the wholesale distribution of medicines to healthcare institutions, retail sales th...
Universal Health International Group Holding Ltd. Financial Statement Overview
Summary
Income Statement
25
Negative
Balance Sheet
45
Neutral
Cash Flow
20
Very Negative
| Breakdown | TTM | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 532.73M | 711.51M | 1.09B | 1.30B | 1.27B | 1.19B |
| Gross Profit | 83.13M | 106.49M | 179.88M | 222.60M | 215.32M | 56.19M |
| EBITDA | -549.51K | -11.85M | 12.59M | -70.62M | -160.78M | -560.83M |
| Net Income | -23.95M | -26.01M | 413.00K | -105.40M | -187.65M | -675.40M |
Balance Sheet | ||||||
| Total Assets | 484.57M | 447.60M | 692.88M | 797.10M | 983.55M | 1.15B |
| Cash, Cash Equivalents and Short-Term Investments | 95.07M | 13.40M | 36.92M | 89.37M | 58.63M | 33.09M |
| Total Debt | 64.73M | 25.00M | 70.60M | 40.62M | 40.00M | 3.93M |
| Total Liabilities | 142.38M | 130.03M | 339.99M | 457.57M | 504.47M | 459.02M |
| Stockholders Equity | 342.19M | 317.57M | 352.72M | 314.73M | 408.13M | 574.97M |
Cash Flow | ||||||
| Free Cash Flow | 20.74M | 0.00 | -101.75M | -19.47M | -47.94M | -126.92M |
| Operating Cash Flow | 20.76M | 0.00 | -101.73M | -19.40M | -47.81M | -124.67M |
| Investing Cash Flow | 6.26M | 0.00 | 54.88M | -8.02M | 11.09M | 19.72M |
| Financing Cash Flow | 21.86M | 0.00 | 40.23M | 11.27M | 55.96M | -10.21M |
Universal Health International Group Holding Ltd. Technical Analysis
Neutral
1.67
Price Trends
1.17
Negative
1.49
Negative
1.45
Negative
Market Momentum
-0.10
Negative
45.93
Neutral
63.89
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:2211, the sentiment is Neutral. The current price of 1.67 is above the 20-day moving average (MA) of 0.57, above the 50-day MA of 1.17, and above the 200-day MA of 1.45, indicating a neutral trend. The MACD of -0.10 indicates Negative momentum. The RSI at 45.93 is Neutral, neither overbought nor oversold. The STOCH value of 63.89 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for HK:2211.
Universal Health International Group Holding Ltd. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | HK$364.43M | 4.98 | 4.28% | 7.10% | -2.88% | -22.83% | |
58 Neutral | HK$68.54M | -6.14 | -7.26% | ― | -34.73% | -4642.86% | |
56 Neutral | HK$291.12M | 24.91 | 1.78% | 5.87% | -10.78% | -82.81% | |
53 Neutral | HK$254.79M | 15.20 | 2.98% | 28.00% | -1.68% | -111.10% | |
52 Neutral | HK$3.74B | -13.26 | 11.40% | ― | 79.98% | -3.40% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
40 Underperform | HK$221.32M | 10.43 | -34.76% | ― | 6.10% | -115.12% |
* Healthcare Sector Average
HK:2211
Universal Health International Group Holding Ltd.
0.62
-0.40
-39.22%
HK:1110
Kingworld Medicines Group Ltd.
0.48
0.06
14.29%
HK:2197
Clover Biopharmaceuticals Ltd.
2.88
2.68
1340.00%
HK:2393
Yestar Healthcare Holdings Co Ltd
0.10
0.02
35.71%
HK:3390
Tycoon Group Holdings Limited
0.29
-3.18
-91.76%
HK:0722
UMP Healthcare Holdings Limited
0.46
0.08
21.98%
Universal Health International Group Holding Ltd. Corporate Events
Universal Health International Secures Unanimous Approval at AGM
Dec 11, 2025
Universal Health International Group Holding Ltd. held its Annual General Meeting on December 11, 2025, where all proposed resolutions were unanimously approved by shareholders. The resolutions included the adoption of financial statements, re-ele...
Universal Health International Announces 2025 AGM and Key Resolutions
Nov 14, 2025
Universal Health International Group Holding Ltd. has announced its upcoming annual general meeting scheduled for December 11, 2025, in Shenyang City, China. The meeting will address several key resolutions, including the adoption of financial sta...
Universal Health International Proposes Modernization of Articles of Association
Nov 10, 2025
Universal Health International Group Holding Ltd. announced proposed amendments to its Articles of Association to align with updated Listing Rules and Cayman Islands laws. Key changes include enabling electronic communication, hybrid meetings, ele...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.